FHT-1015

FHT-1015 is an inhibitor of ATPases used in studies of enzyme regulation. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to catalytic activity, substrate turnover, and enzymatic regulation in cancer, cell signaling, and epigenetics models.

By inhibiting ATPases, FHT-1015 can be used to examine catalytic activity, substrate turnover, and enzymatic regulation. This target class is commonly examined through enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping. In cancer, cell signaling, and epigenetics models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving ATPases
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling
• Phenotypic profiling in cancer, cell signaling, and epigenetics models

Overall, FHT-1015 is appropriate when a defined chemical perturbant is needed to connect ATPases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and epigenetics models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.